Effects of probiotics on hypertension
- PMID: 36646911
- DOI: 10.1007/s00253-023-12369-8
Effects of probiotics on hypertension
Abstract
Emerging data have suggested that probiotics had good potential in regulating intestinal flora and preventing hypertension. Some studies in human and animal models have demonstrated probiotic intervention could attenuate hypertension, regulate intestinal flora to increase the abundance of beneficial bacteria, and regulate intestinal microbial metabolites such as trimethylamine oxide, short-chain fatty acids, and polyphenols. However, there is still some debate as to whether probiotics exert effective benefits. These recently published reviews did not systematically expound on the heterogeneity between the effect and mechanism of probiotics with different types, doses, and carriers to exert antihypertensive effects, as well as the possible application of probiotics in the prevention and treatment of hypertension in food and clinic. Here we try to systematically review the association between hypertension and intestinal microflora, the effect of probiotics and their metabolites on hypertension, and the recent research progress on the specific mechanism of probiotics on hypertension. In addition, we also summarized the potential application of probiotics in antihypertension. Future challenges include elucidating the functions of metabolites produced by microorganisms and their downstream pathway or molecules, identifying specific strains, not just microbial communities, and developing therapeutic interventions that target hypertension by modulation of gut microbes and metabolites.
Keywords: Angiotensin-converting enzyme; Gut microbiome; Hypertension; Probiotic; Short-chain fatty acids.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Gut microbiota and hypertension: association, mechanisms and treatment.Clin Exp Hypertens. 2023 Dec 31;45(1):2195135. doi: 10.1080/10641963.2023.2195135. Clin Exp Hypertens. 2023. PMID: 36994745 Review.
-
Hypertension Programmed by Perinatal High-Fat Diet: Effect of Maternal Gut Microbiota-Targeted Therapy.Nutrients. 2019 Dec 2;11(12):2908. doi: 10.3390/nu11122908. Nutrients. 2019. PMID: 31810197 Free PMC article.
-
GUT Microbiome-GUT Dysbiosis-Arterial Hypertension: New Horizons.Curr Hypertens Rev. 2019;15(1):40-46. doi: 10.2174/1573402114666180613080439. Curr Hypertens Rev. 2019. PMID: 29895255 Review.
-
Probiotics, prebiotics, and synbiotics.Adv Biochem Eng Biotechnol. 2008;111:1-66. doi: 10.1007/10_2008_097. Adv Biochem Eng Biotechnol. 2008. PMID: 18461293 Review.
-
Probiotics ameliorate IgA nephropathy by improving gut dysbiosis and blunting NLRP3 signaling.J Transl Med. 2022 Aug 29;20(1):382. doi: 10.1186/s12967-022-03585-3. J Transl Med. 2022. PMID: 36038927 Free PMC article.
Cited by
-
Limosilactobacillus fermentum Strains as Novel Probiotic Candidates to Promote Host Health Benefits and Development of Biotherapeutics: A Comprehensive Review.Probiotics Antimicrob Proteins. 2024 Aug;16(4):1483-1498. doi: 10.1007/s12602-024-10235-1. Epub 2024 Feb 23. Probiotics Antimicrob Proteins. 2024. PMID: 38393628 Review.
-
Genetically engineered Lactobacillus paracasei rescues colonic angiotensin converting enzyme 2 (ACE2) and attenuates hypertension in female Ace2 knock out rats.Pharmacol Res. 2023 Oct;196:106920. doi: 10.1016/j.phrs.2023.106920. Epub 2023 Sep 14. Pharmacol Res. 2023. PMID: 37716548 Free PMC article.
-
Bacterial live therapeutics for human diseases.Mol Syst Biol. 2024 Dec;20(12):1261-1281. doi: 10.1038/s44320-024-00067-0. Epub 2024 Oct 23. Mol Syst Biol. 2024. PMID: 39443745 Free PMC article. Review.
-
Gut microbiota: a potential new regulator of hypertension.Front Cardiovasc Med. 2024 Jun 27;11:1333005. doi: 10.3389/fcvm.2024.1333005. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38993521 Free PMC article. Review.
-
Probiotics: functional food ingredients with the potential to reduce hypertension.Front Cell Infect Microbiol. 2023 Jul 3;13:1220877. doi: 10.3389/fcimb.2023.1220877. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37465757 Free PMC article. Review.
References
-
- Abais-Battad JM, Alsheikh AJ, Pan X, Fehrenbach DJ, Dasinger JH, Lund H, Roberts ML, Kriegel AJ, Cowley AW Jr, Kidambi S, Kotchen TA, Liu P, Liang M, Mattson DL (2019) Dietary effects on Dahl salt-sensitive hypertension, renal damage, and the T lymphocyte transcriptome. Hypertension 74(4):854–863
-
- Agerholm-Larsen L, Raben A, Haulrik N, Hansen A, Manders M, Astrup A (2000) Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr 54(4):288–297
-
- Aguilar A (2017) Microbiota under pressure. Nat Rev Nephrol 13(1):3–3
-
- Ahmadmehrabi STWHW (2017) Gut microbiome and its role in cardiovascular diseases. Curr Opin Cardiol 32(6):761
-
- Ahtesh FB, Stojanovska L, Apostolopoulos V (2017) Processing and sensory characteristics of a fermented low-fat skim milk drink containing bioactive antihypertensive peptides, a functional milk product. Int J Dairy Technol 71:230–239
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical